ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
cobadiga
|
261 |
66K |
10 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
66K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
cobadiga
|
261 |
66K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
66K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
cobadiga
|
317 |
80K |
17 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
317
|
80K
|
17
|
|
ASX - By Stock
|
IHL |
Re:
Seeking holder account number from computershare US
|
|
cobadiga
|
19 |
7.6K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
19
|
7.6K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
cobadiga
|
13K |
6.3M |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
cobadiga
|
13K |
6.3M |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
cobadiga
|
13K |
6.3M |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: US patent allowed for CHM 0201 (CORE-NK) technology
|
|
cobadiga
|
15 |
5.2K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
15
|
5.2K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
cobadiga
|
62 |
16K |
21 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
cobadiga
|
58 |
17K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
17K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Clinical milestones for 2024 & 2023 successes highlighted
|
|
cobadiga
|
26 |
9.2K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
26
|
9.2K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
cobadiga
|
19K |
6.5M |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
19K
|
6.5M
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Dr Thomas Duthy appointed as Non-Executive Director
|
|
cobadiga
|
32 |
7.4K |
4 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
32
|
7.4K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
cobadiga
|
34 |
10K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
34
|
10K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
cobadiga
|
77 |
37K |
2 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
77
|
37K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
cobadiga
|
19K |
6.5M |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
19K
|
6.5M
|
6
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
cobadiga
|
19K |
6.5M |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
19K
|
6.5M
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
cobadiga
|
34 |
10K |
5 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
34
|
10K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
cobadiga
|
19K |
6.5M |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
19K
|
6.5M
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Incannex completes final dosing for Psi-gad
|
|
cobadiga
|
95 |
21K |
1 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
95
|
21K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US
|
|
cobadiga
|
21 |
7.2K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
21
|
7.2K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
cobadiga
|
13K |
6.3M |
7 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
13K
|
6.3M
|
7
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
cobadiga
|
975 |
277K |
9 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
975
|
277K
|
9
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 Spotlight Presentation
|
|
cobadiga
|
20 |
10K |
3 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
20
|
10K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Trading on NASDAQ
|
|
cobadiga
|
307 |
114K |
2 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
307
|
114K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $3.5 Million at a Premium
|
|
cobadiga
|
60 |
14K |
9 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
60
|
14K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
cobadiga
|
19K |
6.5M |
9 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
19K
|
6.5M
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
cobadiga
|
422 |
146K |
3 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
422
|
146K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
cobadiga
|
422 |
146K |
4 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
422
|
146K
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Computershare to be Appointed as US Transfer Agent
|
|
cobadiga
|
140 |
49K |
1 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
140
|
49K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Trading on NASDAQ
|
|
cobadiga
|
307 |
114K |
12 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
307
|
114K
|
12
|
|
ASX - By Stock
|
IHL |
Re:
Trading on NASDAQ
|
|
cobadiga
|
307 |
114K |
7 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
307
|
114K
|
7
|
|
ASX - By Stock
|
IHL |
Re:
Trading on NASDAQ
|
|
cobadiga
|
307 |
114K |
3 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
307
|
114K
|
3
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
cobadiga
|
32K |
15M |
7 |
30/11/23 |
30/11/23 |
Charts
|
32K
|
15M
|
7
|
|
ASX - By Stock
|
IHL |
Re:
Missing shares 17/10/2023
|
|
cobadiga
|
359 |
98K |
5 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
359
|
98K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Removal from Official List
|
|
cobadiga
|
38 |
11K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
38
|
11K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Removal from Official List
|
|
cobadiga
|
38 |
11K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
38
|
11K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Removal from Official List
|
|
cobadiga
|
38 |
11K |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
38
|
11K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells
|
|
cobadiga
|
79 |
20K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
79
|
20K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
cobadiga
|
975 |
277K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
975
|
277K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
cobadiga
|
99 |
31K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
99
|
31K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
cobadiga
|
70 |
20K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
70
|
20K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
cobadiga
|
70 |
20K |
3 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
cobadiga
|
7 |
2.3K |
0 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
cobadiga
|
70 |
20K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
cobadiga
|
70 |
20K |
3 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
cobadiga
|
70 |
20K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
cobadiga
|
99 |
31K |
3 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
99
|
31K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
cobadiga
|
70 |
20K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
cobadiga
|
70 |
20K |
5 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
5
|
|